Veritable’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-17,594
Closed -$1.42M 551
2023
Q2
$1.42M Buy
17,594
+1,204
+7% +$98.4K 0.02% 298
2023
Q1
$1.3M Buy
16,390
+1,672
+11% +$119K 0.02% 307
2022
Q4
$996K Buy
14,718
+2,066
+16% +$121K 0.02% 360
2022
Q3
$630K Sell
12,652
-462
-4% -$24.7K 0.01% 446
2022
Q2
$731K Buy
13,114
+1,230
+10% +$68.3K 0.01% 447
2022
Q1
$660K Buy
11,884
+2,598
+28% +$133K 0.01% 490
2021
Q4
$520K Sell
9,286
-20
-0.2% -$1.08K 0.01% 555
2021
Q3
$447K Sell
9,306
-98
-1% -$4.74K 0.01% 577
2021
Q2
$394K Buy
9,404
+408
+5% +$15.8K 0.01% 606
2021
Q1
$303K Buy
8,996
+1,762
+24% +$62.8K 0.01% 657
2020
Q4
$253K Sell
7,234
-204
-3% -$7.05K ﹤0.01% 679
2020
Q3
$258K Sell
7,438
-470
-6% -$15.7K 0.01% 621
2020
Q2
$259K Buy
+7,908
New +$252K 0.01% 629
2018
Q1
Sell
-11,946
Closed -$322K 821
2017
Q4
$322K Buy
+11,946
New +$304K 0.01% 612
2016
Q4
Sell
-26,334
Closed -$548K 769
2016
Q3
$548K Buy
26,334
+4,558
+21% +$113K 0.01% 447
2016
Q2
$586K Sell
21,776
-3,982
-15% -$109K 0.01% 410
2016
Q1
$698K Hold
25,758
0.02% 364
2015
Q4
$748K Sell
25,758
-452
-2% -$12.5K 0.02% 371
2015
Q3
$711K Buy
26,210
+182
+0.7% +$5.15K 0.02% 369
2015
Q2
$713K Sell
26,028
-32,982
-56% -$927K 0.02% 380
2015
Q1
$1.57M Sell
59,010
-748
-1% -$17.2K 0.03% 299
2014
Q4
$1.26M Sell
59,758
-1,038
-2% -$23.2K 0.03% 353
2014
Q3
$1.45M Buy
60,796
+6,150
+11% +$142K 0.03% 311
2014
Q2
$1.26M Buy
54,646
+5,894
+12% +$130K 0.03% 355
2014
Q1
$1.11M Buy
48,752
+8,472
+21% +$180K 0.02% 376
2013
Q4
$744K Sell
40,280
-9,060
-18% -$158K 0.02% 458
2013
Q3
$835K Buy
49,340
+5,820
+13% +$97.9K 0.02% 428
2013
Q2
$674K Buy
+43,520
New +$724K 0.02% 493

Other funds holding NVO